Khalequ Zaman

epidemiologist

Khalequ Zaman is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-1982-6879

P108employerInternational Centre for Diarrhoeal Disease Research, BangladeshQ2945843
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q941167832855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study
Q28396900A prospective cohort study of stroke mortality and arsenic in drinking water in Bangladeshi adults
Q90128017A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants
Q64119992Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial
Q52579975Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.
Q36314435Assessment of population structure and major circulating phylogeographical clades of Mycobacterium tuberculosis complex in Bangladesh suggests a high prevalence of a specific subclade of ancient M. tuberculosis genotypes
Q112638071Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study
Q89999663Can Cholera "Hotspots" be Converted to Cholera "Coldspots" in Cholera Endemic Countries? The Matlab, Bangladesh Experience
Q99610117Can existing improvements of water, sanitation, and hygiene (WASH) in urban slums reduce the burden of typhoid fever in these settings?
Q95848107Case Report: Salmonella Enterica Serovar Paratyphi B Infection in a Febrile Ill Child during Enhanced Passive Surveillance in an Urban Slum in Mirpur, Dhaka
Q91885915Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine
Q43171288Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial
Q40128598Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study
Q92213390Complex task to estimate immune responses to various poliovirus vaccines and vaccination schedules
Q92056426Corrigendum to "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" [Vaccine 37 (2019) 4275-4280]
Q56920752Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study
Q39710479Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh
Q34669133Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414.
Q41206694Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial
Q33781579Factors associated with poor knowledge among adults on tuberculosis in Bangladesh: results from a nationwide survey
Q92781216HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh
Q91729311Health Concerns in Urban Slums: A Glimpse of Things to Come?
Q57470308Health seeking behaviour and delayed management of tuberculosis patients in rural Bangladesh
Q64124152Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial
Q41654818Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial
Q51783086Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial.
Q47255848Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A pha
Q34575952Increased childhood mortality and arsenic in drinking water in Matlab, Bangladesh: a population-based cohort study
Q58823336Influenza Immunization in Pregnancy — Antibody Responses in Mothers and Infants
Q38501139Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh
Q39940156Intussusception surveillance in a rural demographic surveillance area in bangladesh
Q56888929Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study
Q47303982Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh
Q57927674Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons
Q98508243Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata
Q28474022Pulmonary tuberculosis and drug resistance in Dhaka central jail, the largest prison in Bangladesh
Q91278176Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial
Q40404190Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh
Q90686521Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial
Q98162155Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
Q35102554Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh
Q92997256Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study
Q95650950Sequential inactivated and oral poliovirus vaccine schedules: a balancing act
Q34427810Socio economic position in TB prevalence and access to services: results from a population prevalence survey and a facility-based survey in Bangladesh.
Q39645266Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine
Q102206007The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks
Q38695279The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys
Q90870148The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation
Q40263982The effect of exclusive breast-feeding on respiratory illness in young infants in a maternal immunization trial in Bangladesh
Q64124048The predictive performance of a pneumonia severity score in HIV-negative children presenting to hospital in seven low and middle-income countries
Q36131945Two Generations of "Gold Standards": The Impact of a Decade in Hepatitis E Virus Testing Innovation on Population Seroprevalence
Q64982832Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
Q96689995Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever
Q64095027Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera
Q42249800Vaccine for prevention of mild and moderate-to-severe influenza in children

Search more.